The effect of interferon and tyrosine kinase inhibitor sequential therapy for advanced renal cell carcinoma
Not Applicable
Recruiting
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-UMIN000003389
- Lead Sponsor
- Gifu university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) No severe complications 2) Performance status :Eastern cooperative oncology group>=2 or Karnofsky>=80%
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Objective response
- Secondary Outcome Measures
Name Time Method